Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD

Thorax

Volumn 64, Issue 1, 2009, Pages 13-19

  Barreiro, E ^a,b,d   Rabinovich, R ^c   Marin Corral, J ^a,b   Barbera J A ^c   Gea, J ^a,b   Roca, J ^c  

^a HOSPITAL DEL MAR   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACTIN; ALPHA 1 ACTIN; ANTIOXIDANT; CARBON DIOXIDE; CARBONATE DEHYDRATASE III; CARBONYL DERIVATIVE; CONTRACTILE PROTEIN; CREATINE KINASE; DNA; ENOLASE; ENOLASE 3BETA; FRUCTOSE BISPHOSPHATE ALDOLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOGLOBIN; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA REPAIR; ENDURANCE; ENERGY METABOLISM; ENZYME ACTIVITY; EXERCISE; EXERCISE TOLERANCE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; HYDRATION; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MASS SPECTROMETRY; MUSCLE BIOPSY; MUSCLE EXERCISE; MUSCLE LEVEL; MUSCLE STRENGTH; NITRATION; NITROSATIVE STRESS; OXIDATIVE STRESS; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUADRICEPS FEMORIS MUSCLE; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 58349091041     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.105163     Document Type: Article

References (45)

1. Casaburi R, Patessio A, loli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:9-18.
2. Gosselink R, Troosters T, Decramer M. Exercise training in COPD patients: the basic questions. Eur Respir J 1997;10:2884-91.
3. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
4. Sala E, Roca J, Marrades RM, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726-34.
5. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176: 532-55.
6. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
7. Casaburi R, Porszasz J, Burns MR, et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:1541-51.
8. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:555-61.
9. Barreiro E, Gea J, Corominas JM, et al. Nitric oxide synthases and protein oxidation in the quadriceps femoris of COPD patients. Am J Respir Cell Mol Biol 2003;29:771-8.
10. Barreiro E, Gea J, Matar G, et al. Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2005;33:636-42.
11. Barreiro E, de la Puente B, Minguella J, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1116-24.
12. Heunks LM, Vina J, van Herwaarden CL, et al. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999;277:R1697-704.
13. Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2004;169:1022-7.
14. Rabinovich RA, Ardite E, Troosters T, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1114-18.
15. Barreiro E, Galdiz JB, Marinan M, et al. Respiratory loading intensity and diaphragm oxidative stress: N-acetyl-cysteine effects. J Appl Physiol 2006;100:555-63.
16. Rabinovich RA, Ardite E, Mayer AM, et al. Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration 2006;73:757-61.
17. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med 2004;351:2112-14.
18. 2 with small muscle mass exercise. Am J Respir Crit Care Med 2004;169:89-96.
19. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51:819-24.
20. Barreiro E, Schols AM, Polkey Ml, et al. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 2008;63:100-7.
21. Rabinovich RA, Bastos R, Ardite E, et al. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J 2007;29:643-50.
22. Barreiro E, Gea J, Di Falco M, et al. Protein carbonyl formation in the diaphragm. Am J Respir Cell Mol Biol 2005;32:9-17.
23. Coin A, Sergi G, Minicuci N, et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80-year-old Italian population. Clin Nutr 2008;27:87-94.
24. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
25. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
26. Barreiro E, Comtois AS, Gea J, et al. Protein tyrosine nitration in the ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol 2002;26:438-46.
27. Montes de Oca M, Torres SH, De Sanctis J, et al. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 2005;26:390-7.
28. Agustí A, Morlá M, Sauleda J, et al. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 2004;59:483-7.
29. Vassilakopoulos T, Deckman G, Kebbewar M, et al. Regulation of nitric oxide production in limb and ventilatory muscles during chronic exercise training. Am J Physiol Lung Cell Mol Physiol 2003;284:L452-7.
30. Souza JM, Daikhin E, Yudkoff M, et al. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 1999;371:169-78.
31. Castegna A, Thongboonkerd V, Klein JB, et al. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003;85:1394-401.
32. Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007;75:291-302.
33. Gole MD, Souza JM, Choi I, et al. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000;278:L961-7.
34. MacMillan-Crow LA, Crow JP, Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A 1996;93:11853-8.
35. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994;269:29409-15.
36. Souza JM, Choi I, Chen Q, et al. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 2000;380:360-6.
37. Hussain SN, Matar G, Barreiro E, et al. Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats. Am J Physiol Lung Cell Mol Physiol 2006;290:L996-1003.
38. Fugere NA, Ferrington DA, Thompson LV. Protein nitration with aging in the rat semimembranosus and soleus muscles. J Gerontol A Biol Sci Med Sci 2006;61:806-12.
39. Koeck T, Levison B, Hazen SL, et al. Tyrosine nitration impairs mammalian aldolase A activity. Mol Cell Proteomics 2004;3:548-57.
40. Mihm MJ, Coyle CM, Schanbacher BL, et al. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 2001;49:798-807.
41. Nicolis S, Pennati A, Perani E, et al. Easy oxidation and nitration of human myoglobin by nitrite and hydrogen peroxide. Chemistry 2006;12:749-57.
42. Snook JH, Li J, Helmke BP, et al. Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility. Free Radic Biol Med 2008;44:14-23.
43. Dong M, Vongchampa V, Gingipalli L, et al. Development of enzymatic probes of oxidative and nitrosative DNA damage caused by reactive nitrogen species. Mutat Res 2006;594:120-34.
44. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
45. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.